메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kim Moinay (Department of Neurosurgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea.) Jeon Hanwool (Department of Neurosurgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea.Department of Medical Science Asan Medical Institute of Convergence Science and Technology Asan Medic) Chung Yeongu (Department of Neurosurgery Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul Korea.) Lee Si Un (Department of Neurosurgery Seoul National University Bundang Hospital Seongnam Korea.) Park Wonhyoung (Department of Neurosurgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea.) Park Jung Cheol (Department of Neurosurgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea.) Ahn Jae Sung (Department of Neurosurgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea.) Lee Seungjoo (Department of Neurosurgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea.)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.38 No.21
발행연도
2023.5
수록면
1 - 17 (17page)
DOI
10.3346/jkms.2023.38.e161

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Subarachnoid hemorrhage (SAH) patients have oxidative stress results in inflammation, tissue degeneration and neuronal damage. These deleterious effects cause aggravation of the perihematomal edema (PHE), vasospasm, and even hydrocephalus. We hypothesized that antioxidants may have a neuroprotective role in acute aneurysmal SAH (aSAH) patients. Methods: We conducted a prospective, multicenter randomized (single blind) trial between January 2017 and October 2019, investigating whether antioxidants (acetylcysteine and selenium) have the potential to improve the neurologic outcome in aSAH patients. The antioxidant patient group received antioxidants of acetylcysteine (2,000 mg/day) and selenium (1,600 µg/day) intravenously (IV) for 14 days. These drugs were administrated within 24 hours of admission. The non-antioxidant patient group received a placebo IV. Results: In total, 293 patients were enrolled with 103 patients remaining after applying the inclusion and exclusion criteria. No significant differences were observed in the baseline characteristics between the antioxidant (n = 53) and non-antioxidant (n = 50) groups. Among clinical factors, the duration of intensive care unit (ICU) stay was significantly shortened in patients who received antioxidants (11.2, 95% confidence interval [CI], 9.7–14.5 vs. 8.3, 95% CI, 6.2–10.2 days, P = 0.008). However, no beneficial effects were observed on radiological outcomes. Conclusion: In conclusion, antioxidant treatment failed to show the reduction of PHE volume, mid-line shifting, vasospasm and hydrocephalus in acute SAH patients. A significant reduction in ICU stay was observed but need more optimal dosing schedule and precise outcome targets are required to clarify the clinical impacts of antioxidants in these patients.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0